Original Article

Physicians’ STD Diagnosis and Screening Practices in the South

Authors: Yolanda H. Wimberly, MD, MSC, Matthew Hogben, PHD

Abstract

Objectives: Sexually transmitted diseases (STDs) remain at high levels in the South compared with the rest of the nation. Physician diagnosis levels and screening behaviors fall among the elements about which more knowledge is needed to address these high levels. This article assesses Southern physicians’ STD diagnosis histories and screening behaviors, focusing on curable STDs.


Methods: The sample included 1,306 physicians practicing in 13 Southern states and in the District of Columbia. These physicians formed part of a larger survey (n = 4,233) and answered questions concerning STD diagnosis history and screening behaviors. Analyses focus on chlamydial infection and gonorrhea individually, as well as composite statistics for gonorrhea, chlamydial infection, syphilis, pelvic inflammatory disease, trichomoniasis, and nongonococcal urethritis.


Results: Approximately 80% of physicians had diagnosed a curable STD, and 56% screened for any STD. The most common diagnosis techniques were culture and DNA probe. Several variables were individually associated with screening and diagnostic methods. Being female, African-American, or an obstetrician/gynecologist were associated with increased likelihood to screen for STDs in multivariate analyses.


Conclusions: Southern physicians were less likely to screen for STDs than their counterparts in other areas of the United States, although they were more likely to have diagnosed STDs. Results suggest that some targeted and evaluated screening practices may be useful in this area of the country.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Institute of Medicine. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Committee on Prevention and Control of Sexually Transmitted Diseases. Washington, DC: National Academy Press; 1997.
 
2. American Social Health Association. Facts and answers about STDs. Available at www.ashastd.org. Accessed October 20, 2003.
 
3. Centers for Disease Control and Prevention. Tracking the hidden epidemics: trends in STDs in the United States 2000. Washington, DC: U. S. Government Printing Office, 2001.
 
4. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance: 2001. Atlanta, GA: Department of Health and Human Services, 2002.
 
5. Brackbill R, Sternberg M, Fishbein M. Where do people go for treatment of sexually transmitted diseases?Fam Plann Perspect 1999;3:10 –15.
 
6. St. Lawrence JS, Montano DE, Kasprzyk D, et al. STD screening, testing, case reporting, and clinical and partner notification practices: a survey of US physicians. Am J Pub Health 2002;92:1784 –1788.
 
7. Hogben M, St. Lawrence JS, Kasprzyk D, et al. Sexually transmitted disease screening in the United States by obstetricians and gynecologists. Obstet Gynecol 2002;100:801–807.
 
8. McCree DH, Leichliter J, Hogben M, et al. Human Papillomavirus screening by U. S. physicians. Prev Med 2003;36:159 –63.
 
9. McCree DH, Hogben M, St Lawrence JS. Differences among physician treatment practices for gonorrhea, syphilis, and chlamydia in the United States. Sex Transm Inf 2003;79:254 –256.
 
10. U. S. Preventive Services Task Force. Guide to Clinical Preventive Services, 2nd Edition. Washington, DC: U. S. Department of Health and Human Services, 1996.
 
11. Todd CS, Haase CE, Stoner BP. Prevalence of asymptomatic gonococcal and chlamydial infections in an emergency department population. International Society for STD Research, Thirteenth Meeting, Abstract No. 47, July 11–14, 1999, Denver, CO.
 
12. McNagny SE, Parker RM, Zenilman JM, et al. Urinary leukocyte esterase test: a screening method for asymptomatic chlamydial and gonococcal infection in men. J Infect Dis 1992;165:573–576.
 
13. Mehta SD, Rothman RE, Kellen GD, et al. Unsuspected gonorrhea and chlamydia in patients of an urban adult emergency department: a critical population for STD control intervention. Sex Transm Dis2001 Jan; 28(1):33–39.
 
14. Mehta SD, Bishai D, Howell MR, et al. Cost-effectiveness of five strategies for gonorrhea and chlamydia control among female and male emergency department patients. Sex Transm Dis 2002 Feb;29(2):83–91.
 
15. Lewis C, Freeman H. The sexual history-taking and counseling practices of primary care physicians. Western J Med 147;165–167.
 
16. Centers for Disease Control and Prevention. HIV Prevention Practices of Primary Care Physicians.MMWR Morb Mortal Wkly Rep 1994;42(51)988 –992.
 
17. Lafferty WE, Downey L, Holan C, et al. Provision of sexual health services to adolescent enrollees in Medicaid managed care. Am J Public Health 2002 Nov;92(11):1779 –1783.
 
18. Tao G, Irwin K, Kassler W. Missed opportunities to assess sexually transmitted diseases in US adults during routine medical checkups. Am J Prev Med 2000;18:109 –114.
 
19. Gemson D, Colombotos J, Elinson J et al. Acquired immunodeficiency syndrome prevention: knowledge, attitudes, and practices of primary care physicians. Arch Intern Med 151;1102–1108.
 
20. McCance KL, Moser R, Smith K. A survey of physicians’ knowledge and application of AIDS prevention capabilities. Am J Prev Med 1991;7(3):141–145.
 
21. Schuster MA, Bell RM, Peterson LP, et al. Communication between adolescents and physicians about sexual behavior and risk prevention. Arch Pediatr Adolesc Med 1996;150(9):906 –913.